1.35
1.35 (0%)
As of Feb 14, 2025
Harvard Bioscience Inc [HBIO]
Source:
Company Overview
Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development.
| Country | United States |
| Headquarters | holliston, massachusetts |
| Phone Number | ( 508 ) 893-8999 |
| Industry | manufacturing |
| CEO | James Green |
| Website | www.harvardbioscience.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $94.1 |
| Operating Profit | $-6.2 |
| Net Income | $-12.4 |
| Net Cash | $-0.2 |
Profit Ratios
| Gross Margin | $54.8 |
| Operating Margin | -6.6 |
| Profit as % of Revenues | -441.5% |
| Profit as % of Assets | -9.4% |
| Profit as % of Stockholder Equity | -19.6% |
Management Effectiveness
| Return on Equity | -19.6% |
| Return on Assets | -9.8% |
| Turnover Ratio | 71.3% |
| EBITA | $-1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $126.6 |
| Total Liabilities | $63.3 |
| Operating Cash Flow | $1.4 |
| Investing Cash Flow | $-1.3 |
| Financing Cash Flow | $-0.1 |
